Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression

Area of Science:

• Oncology
• Molecular Biology
• Endocrinology

Background:

• The role of Estrogen Receptor beta (ERβ) in prostate cancer remains unclear, with its loss correlating with aggressive disease.
• Mice lacking ERβ do not develop prostate cancer, suggesting its loss may be a consequence and requirement for tumorigenesis.

Purpose of the Study:

• To investigate the hypothesis that ERβ loss is a consequence of tumorigenesis and necessary for prostate cancer development.
• To elucidate the mechanism by which ERβ is repressed in PTEN-deficient prostate cancer.

Main Methods:

• Analysis of ERβ expression in PTEN-deleted prostate cancer models.
• Investigating the role of BMI-1 in ERβ transcriptional repression.
• Examining the interplay between PTEN deletion, BMI-1, ERβ, and HIF-1/VEGF signaling.

Main Results:

• ERβ is repressed in prostate cancer resulting from PTEN deletion.
• BMI-1, induced by PTEN deletion, directly represses ERβ transcription.
• ERβ repression facilitates HIF-1/VEGF signaling, sustaining BMI-1 expression, creating a positive feedback loop.

Conclusions:

• ERβ loss is not causative but rather a consequence and facilitator of prostate tumorigenesis initiated by PTEN loss.
• BMI-1-mediated repression of ERβ is a key mechanism regulating ERβ expression in prostate cancer.
• A positive feedback loop involving PTEN loss, BMI-1, ERβ repression, and HIF-1/VEGF signaling drives prostate tumorigenesis.